Sontuzumab, CAS 372075-37-1

Product Description: Sontuzumab (AS1402) is a humanizedised IgG1κ MUC1 specific monoclonal antibody. Sontuzumab binds the extracellular MUC1 peptide sequence PDTR with a Kd of ~1 nM. Sontuzumab can be used for the research of breast cancer[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Pegram MD, et al. Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer. Breast Cancer Res. 2009;11(5):R73./[2]Snijdewint FG, et al. Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients. Int J Cancer. 2001 Jul 1;93(1):97-106.

CAS Number: 372075-37-1

Molecular Weight: N/A

Compound Purity: 99.66

Research Area: Cancer

Solubility: H2O

Target: Others

• SKU: MEXHY-P99591-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99591-10
• Package Unit: 10 mg
• Quantity Unit: STK
• Conjugate: Unconjugated